PCN93 Cost-Effectiveness Analysis of DEB-TACE Compared to Lipiodol-TACE As First LINE Treatment for Unresectable HCC

Abstract

Authors

G. Andreozzi V. Lorenzoni I. Bargellini R. Cioni G. Turchetti

Full Text Cite This Article
Back to Volume 23, Supplemental S2
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×